Biopharmaceutical Contract Manufacturing Market Growth Analysis, Share, Demand by Regions, Research Forecasts to 2026


Biopharmaceutical Contract Manufacturing Market.jpeg
Contract manufacturing organizations (CMOs) provide wide range of manufacturing services, which include contract packaging, quality testing, and development service to pharmaceutical and biotechnology industries. Biopharmaceutical companies prefer CMOs due to complexity in manufacturing process of biomolecules, as they consists of different shape, size, and behavior with significantly complex process than pharmaceutical drugs. Contract manufacturing organizations provide services from development of biologics to commercial scale production. Few companies also provide cell line development, fermentation, process optimization, and analytical characterization. Improved efficiency, weak product pipeline, and increasing price pressure is expected to favor the growth of biopharmaceutical contract manufacturing market in near future.

Global Biopharmaceutical Contract Manufacturing Market Taxonomy:

On the basis of contract type, product type, and therapeutic application, global biopharmaceutical contract manufacturing market is segmented into:

By Contract Type:

Active Pharmaceutical Ingredient (API)
Fill-And-Finished

By Product Type:

Interferons
Monoclonal Antibodies
Recombinant Hormone
Proteins
Vaccines
Vitamins
Insulin
Others

By Therapeutic Applications:

Oncology
Autoimmune Diseases
Metabolic Diseases
Cardiovascular Diseases
Neurology
Infectious Diseases
Others

Increasing outsourcing services in biopharmaceutical industry is expected to fuel the growth of biopharmaceutical contract manufacturing market

Pelican Therapeutics and subsidiary of Heat Biologics entered into a manufacturing agreement with KBI Biopharma in September, 2017. As per the agreement, KBI biopharma will provide development and manufacturing service under biopharmaceutical contract development and manufacturing organization (CDMO) for cGMP production of an antibody (PTX-35) and a fusion protein (PTX-15). Pelican Therapeutics intends to develop immunotherapy drugs by mimicking the production of antigen-specific T-cells. In May 2016, pelican received grant around US$ 15.2 million by Cancer Prevention and Research Institute of Texas (CPRIT) to its manufacturing efforts in immunotherapies for lung, pancreatic, lymphoma, prostate, and ovarian cancers.

Ajinomoto Althea, Inc., announced a GMP production suite in newly established High Potency Products (HPP) manufacturing site located in San Diego, California, in September 2017. Currently, Althea is offering process development and analytical services to the clients and from November 2017, the company will provide facilities for GMP manufacturing of bioconjugation and complex formulation. Apart from this services, Althea is aiming to provide full manufacturing services including fill-and-finish, which will start off in 2018.

Archaogen, Inc., received contract value from Biomedical Advanced Research and Development Authority (BARDA) around US$ 18 million in the support of product development, named C-Scape in September 2017. It is an orally administered antibacterial candidate developed to treat bacterial infections caused by the family of Enterobacteriaceae producing Extended Spectrum Beta-Lactamase (ESBL).

According to the annual report of BioPlan Associates, 2017, ongoing trends influencing the biopharmaceutical manufacturing growth are increasing international manufacturing centers, which include China and expansion of biosimilars and cell-and-gene therapy approvals.


Reducing cost and focusing on core strengths is expected to fuel the growth of biopharmaceutical contract manufacturing market

According to the Journal of Pharmaceutical Manufacturing in 2017, major factors driving the growth of biopharmaceutical contract manufacturing market include minimizing risk by outsourcing with other biopharma to achieve efficient product in minimum time interval, switching over the large biopharma companies to strengthen the weak pipeline product, and to cut off the costs of product development without risking financial investments. Moreover, CMOs offer services to companies lacking the capability to develop formula or product.

The key players in biopharmaceutical contract manufacturing market include Lonza Group Ltd., ProBioGen AG, Boehringher Ingelheim, BIOMEVA GmbH, Celonic GmbH, Sandoz, Fujifilm Diosynth Biotechnology, and Rentschler Biotechnologie.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.


Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702

Comments

Post a Comment

Popular posts from this blog

Why the Cold Pain Therapy is a Growing Payer Opportunity?

Image
Cold pain therapy is a therapeutic application of cold, used in the treatment of acute soft tissue injuries and to reduce the pain in post-operative condition in orthopedic surgeries, treatment of benign and malignant lesions, and in pain management. Cryotherapy can be applied topically (on the skin surface), surgically or percutaneously. This can also be used to treat various skin conditions such as oral mucositis and tumors in the liver, kidney, bones, breasts and lungs, skin tumors, skin tags, pre-cancerous skin moles, and injuries. Cryosurgery procedure involves use of extreme cold, produced with help of liquid nitrogen (or argon gas) to destroy abnormal tissues. According to the National Cancer Institute (NCI), cryosurgery is used for treatment of several types of cancers and some non-cancerous conditions. It is reported to be effective for treatment in early stage skin cancer, retinoblastoma, actinic keratosis, and cervical intraepithelial neoplasia. Accord...
Read more

Ursodeoxycholic Acid Market Shows Boosted Growth Rate 2018-2026 Estimated by Global Top Players

Image
Ursodeoxycholic acid (UDCA) is a bile acid taken as either a tablet or liquid to treat gallstones and to treat and prevent the progression of cystic fibrosis-related liver disorder. UDCA modifies the bile acid pool by decreasing levels of hydrophobic bile acids while increasing proportion of nontoxic hydrophilic bile acids. UDCA can delay development of gastroesophageal varices and progression to cirrhosis. Moreover it can improve long-term survival in patients with primary biliary cirrhosis. Significant improvement in liver health can be achieved during UDCA therapy in patients with intrahepatic cholestasis of pregnancy, primary sclerosing cholangitis, nonalcoholic fatty liver disease, cystic fibrosis-associated liver disease, total parenteral nutrition-induced cholestasis, graft related liver disease, and in some pediatric cholestatic liver diseases. The global ursodeoxycholic acid market size was valued at US$ 346.2 million in 2017, and is expected to witn...
Read more

Booms and Busts in Anatomic Pathology Market; Dynamics Trends Over The Time Discussed 2018-2026

Image
Anatomic pathology involves direct visualization of human tissue as gross examination as well as under a microscope for proper diagnosis of the disease or a pathological condition. Subtypes of anatomic pathology include surgical pathology, oral and maxillofacial pathology, cytopathology, molecular pathology, and forensic pathology. Procedures performed in anatomic pathology include gross examination, histopathology, immunohistochemistry, in situ hybridization, cryopathology, tissue cytogenetics, and others. Standard approach in anatomical pathology is microscopic examination of tissue samples with the help of one or more stains. Manufacturers have developed stains to identify and classify microorganisms in biopsy of tissue samples or excisional specimens. Various gram stains and acid-fast stains have applications in detection of bacteria and mycobacteria in tissue samples. Commercially available products include tissue processing systems, microtomes, cryostats, ...
Read more